AUTHORS
Ruby Honjol, Allison Banuelos, PhD2, Irving Weissman, MD3
AFFILIATIONS
1 Stanford University School of Medicine, Stanford, California, United States
2 Stanford University School of Medicine, Stanford, California, United States
3 Stanford University School of Medicine, Stanford, California, United States
ABSTRACT
Long-term hematopoietic stem cells (LT-HSCs) sustain lifelong hematopoiesis through self-renewal and are responsible for durable hematopoietic reconstitution following transplantation. Although hematopoietic stem cells can be detected in peripheral blood, they comprise less than 0.01% of circulating nucleated cells, and whether these rare circulating HSCs represent bona fide LT-HSCs remains unknown. We previously identified Hoxb5 as a highly specific marker of LT-HSCs, enabling their prospective isolation and in vivo tracking. Here, we investigated the fate of Hoxb5⁺ LT-HSCs during physiological homeostasis and clinically relevant hematopoietic stem cell mobilization.
Using Hoxb5-mCherry reporter mice, HSC mobilization was induced with cyclophosphamide followed by two daily doses of G-CSF. Despite robust mobilization of phenotypic HSCs, the vast majority of Hoxb5⁺ LT-HSCs remained within the bone marrow, with only a small fraction detected in the spleen, liver, and peripheral blood. Accordingly, the frequency of Hoxb5⁺ LT-HSCs within the bone marrow remained largely unchanged following mobilization. Notably, fewer than 10% of phenotypic HSCs recovered from mobilized peripheral blood expressed Hoxb5, demonstrating that the circulating HSC compartment is composed predominantly of Hoxb5⁻ cells.
To determine whether retained LT-HSCs underwent differentiation during mobilization, Hoxb5-CreER;Rosa26-ZsGreen lineage-tracing mice were analyzed following CY/G-CSF treatment. The vast majority of labeled Hoxb5⁺ LT-HSCs retained their identity, with minimal contribution to Hoxb5⁻ HSCs, short-term HSCs, or downstream progenitors. Consistent with limited differentiation, fewer than 1% of circulating ZsGreen⁺ cells were detected in peripheral blood and were composed predominantly of mature CD11b⁺ myeloid cells.
To determine whether limited trafficking is an intrinsic property of Hoxb5⁺ LT-HSCs, steady-state parabiosis was performed using Hoxb5-mCherry reporter mice. Despite complete equilibration of circulating blood cells between parabionts, Hoxb5⁺ LT-HSCs failed to equilibrate between partners, demonstrating minimal physiological trafficking between bone marrow niches. Finally, Hoxb5-mCherry⁺ and Hoxb5-mCherry⁻ HSCs isolated following mobilization were transplanted into lethally irradiated CD45.1 recipients. Hoxb5-mCherry⁺ LT-HSCs retained robust long-term multilineage reconstitution, whereas Hoxb5-mCherry⁻ HSCs exhibited minimal durable engraftment.
Together, these findings reveal that bona fide Hoxb5⁺ LT-HSCs are selectively retained within the bone marrow, resisting both physiological trafficking and pharmacologic mobilization while preserving robust long-term regenerative capacity. In contrast, the majority of HSCs recovered from mobilized peripheral blood are Hoxb5⁻ and exhibit limited durable engraftment, demonstrating that the mobilized HSC compartment is compositionally and functionally distinct from the bona fide LT-HSC population retained within the bone marrow. These findings challenge the longstanding assumption that mobilized peripheral blood HSCs faithfully represent the long-term regenerative stem cell compartment and raise the fundamental question of what mechanisms selectively retain the most potent self-renewing HSCs within their native niche. Defining these mechanisms may inform the development of next-generation mobilization strategies that more effectively recruit LT-HSCs for hematopoietic stem cell transplantation.
DISCLOSURES
Allison Banuelos, PhD: No relevant conflicts of interest to declare.